We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Automated Methods Evaluated for Von Willebrand Factor Activity

By LabMedica International staff writers
Posted on 12 Jun 2014
Image: The Sysmex CS2000i fully automated blood coagulation analyzer (Photo courtesy of Siemens).
Image: The Sysmex CS2000i fully automated blood coagulation analyzer (Photo courtesy of Siemens).
Von Willebrand factor (VWF) assays have an important role in the diagnostic evaluation, and treatment monitoring, of von Willebrand disease (VWD), which is one of the most common coagulopathies or bleeding disorders.

The laboratory evaluation for VWD requires an assessment of plasma VWF activity, which is commonly done using an aggregometer to assess VWF ristocetin cofactor activity which is a quantitative method that uses the antibiotic ristocetin to induce plasma VWF binding to the VWF receptor on target platelets and platelet agglutination.

Scientists at the McMaster University (Hamilton, ON, Canada) evaluated 262 samples from 217 patients that included 188 samples from 153 females and 73 samples from 63 males. There were 197 samples from adults (ages 18 to 84) and 64 from children (ages 0 to 17 years), and 67 samples were from 34 patients with previously diagnosed VWD. After validating that the assay could be performed on an instrument from a different manufacturer, they compared VWF activity assay (VWF:Ac) to VWF ristocetin cofactor activity (VWF:RCo) findings, including ratios of activity/antigen.

Plasma was tested by the VWF:Ac on an STA-R Evolution (Diagnostica Stago; Parsippany, NJ, USA) and using the Innovance assay on a Sysmex CS2000i instrument (Siemens; Erlangen, Germany). VWF:RCo was performed by aggregometry on a Helena AggRAM instrument (Helena Laboratories, Beaumont, TX, USA). There was excellent correlation between VWF:Ac results run at two different sites on two different instruments. VWF:Ac had greater precision and sensitivity to low levels of VWF than the VWF:RCo method.

Although there was good correlation between VWF:Ac and VWF:RCo results among healthy controls and patient subjects, VWF:Ac results were undetectable and/or significantly lower than VWF:RCo among patients who had types 2A, 2B, or 2M VWD. Additionally, a higher proportion of patient samples were classified as showing qualitative defects using the VWF:Ac compared with VWF:RCo method.

The authors concluded that the Innovance VWF:Ac method is an acceptable, automated alternative to the VWF:RCo method for assessment of VWF binding to the platelet receptor glycoprotein GPIbα that is sensitive to both quantitative and qualitative defects of VWF. Laboratories and clinicians need to be aware that some patients with VWD have much lower levels of VWF measured by the VWF:Ac assay than by VWF:RCo. The study was published on April 18, 2014, in the International Journal of Laboratory Hematology.

Related Links:

McMaster University 
Diagnostica Stago
Siemens Healthcare



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Drug Testing Assays
Atellica DT 250 Analyzer
New
Gold Member
Connectivity Solution
EKF Link

Channels

Clinical Chemistry

view channel
Image: New evidence now questions whether a single stool-test cutoff should be applied uniformly across all age groups.(Photo courtesy of Paul Maguire - Adobe Stock)

Study Questions Uniform Stool-Test Cutoff Across Age Groups

Colorectal cancer remains a major clinical challenge, ranking as the fourth most common cancer and the second-leading cause of cancer death in the U.K. Early-onset colorectal cancer, defined as diagnosis... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more